Embolic protection during saphenous vein graft interventions.
Stenting of saphenous vein graft (SVG) lesions is associated with a high risk of periprocedural myocardial infarction, due primarily to distal embolization. Although embolic protection devices are the only clinical trial-proven therapy for preventing periprocedural myocardial infarction during SVG interventions, they are currently used in only a small proportion of eligible patients. In this review, we present an update on the clinical data and practical recommendations for using the currently available embolic protection devices during SVG interventions.
Banerjee
Subhash
S
VA North Texas Healthcare System, 4500 S. Lancaster Road (111a), Dallas, TX, 75216, USA. subhash.banerjee@utsouthwestern.edu
Brilakis
Emmanouil S
ES
D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation* / Q000379:methods; D004617:Embolism / Q000517:prevention & control*; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D006801:Humans; D009203:Myocardial Infarction / Q000453:epidemiology; D012039:Regional Blood Flow / Q000502:physiology; D012307:Risk Factors; D012501:Saphenous Vein / Q000503:physiopathology / Q000637:transplantation*